Recent studies have reported occasionally increased radiolabeled PSMA uptake in rib fractures, as well as in benign bone diseases, such as fibrous dysplasia and Paget's disease.39As such findings must be taken into account when reporting PET/CT results, the presence of benign disease was an exclusion criterion for our clinical assay. This evidence concerns the gene FOLH1 and fibrous dysplasia.